Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-19 Sale |
2025-03-21 6:34 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
2,515 | $34.2 | $86,021 | 72,233 (Direct) |
View |
2025-03-19 Sale |
2025-03-21 6:33 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
7,162 | $34.2 | $244,964 | 87,491 (Direct) |
View |
2025-03-19 Sale |
2025-03-21 6:32 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,770 | $34.2 | $197,353 | 108,588 (Direct) |
View |
2025-03-19 Sale |
2025-03-21 6:31 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
17,338 | $34.2 | $593,017 | 1,220,952 (Indirect Direct) |
View |
2025-02-03 Sale |
2025-02-05 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
5,000 | $39.07 | $195,350 | 150,790 (Direct) |
View |
2025-01-03 Sale |
2025-01-07 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
15,000 | $52.09 | $781,350 | 174,290 (Direct) |
View |
2024-12-02 Sale |
2024-12-04 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
10,000 | $57.57 | $575,700 | 1,149,290 (Indirect Direct) |
View |
2024-11-22 Sale |
2024-11-26 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
501 | $56.52 | $28,317 | 51,653 (Direct) |
View |
2024-10-03 Sale |
2024-10-07 07:55 am |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
14,375 | $54.63 | $785,306 | 167,549 (Direct) |
View |
2024-09-26 Sale |
2024-09-30 5:01 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
25,000 | $51.11 | $1,277,750 | 200,092 (Direct) |
View |
2024-09-10 Sale |
2024-09-12 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
1,035 | $51.5 | $53,303 | 68,576 (Direct) |
View |
2024-08-26 Sale |
2024-08-28 4:31 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $53.19 | $159,570 | 69,611 (Direct) |
View |
2024-08-12 Sale |
2024-08-14 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $47.68 | $143,040 | 72,611 (Direct) |
View |
2024-07-25 Sale |
2024-07-26 4:38 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $53.43 | $160,290 | 75,611 (Direct) |
View |
2024-07-25 Sale |
2024-07-26 4:24 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
19,056 | $53.88 | $1,026,737 | 111,092 (Direct) |
View |
2024-07-15 Sale |
2024-07-17 5:35 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
27,000 | $55 | $1,485,000 | 269,680 (Direct) |
View |
2024-07-15 Sale |
2024-07-17 5:14 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
25,000 | $55 | $1,375,000 | 177,092 (Direct) |
View |
2024-07-10 Sale |
2024-07-12 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $48.55 | $145,650 | 78,611 (Direct) |
View |
2024-07-05 Sale |
2024-07-09 6:04 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
15,000 | $44.08 | $661,200 | 159,259 (Direct) |
View |
2024-07-03 Sale |
2024-07-05 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
14,375 | $44.87 | $645,006 | 181,924 (Direct) |
View |
2024-06-28 Sale |
2024-07-02 4:32 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
32,129 | $43.61 | $1,401,146 | 130,148 (Direct) |
View |
2024-06-26 Sale |
2024-06-28 5:31 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
956 | $44.38 | $42,427 | 52,580 (Direct) |
View |
2024-06-25 Sale |
2024-06-26 4:32 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $45.37 | $136,110 | 80,643 (Direct) |
View |
2024-06-24 Sale |
2024-06-25 5:03 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
9,500 | $45.73 | $434,435 | 195,578 (Direct) |
View |
2024-06-21 Sale |
2024-06-24 5:08 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
15,000 | $44.66 | $669,900 | 174,259 (Direct) |
View |
2024-06-10 Sale |
2024-06-11 4:35 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $43.86 | $131,580 | 83,643 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-02 Exercise |
2025-04-04 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
81,270 | $1.91 | 1,302,222 (Direct) |
View |
2025-04-02 Exercise |
2025-04-04 4:30 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
81,270 | $0 | 1,302,222 (Direct) |
View |
2025-03-10 Option Award |
2025-03-11 4:30 pm |
N/A 2035-03-09 |
Crinetics Pharmaceuticals Inc. | CRNX | Schilke Tobin Chief Financial Officer |
132,000 | $0 | 132,000 (Direct) |
View |
2025-02-20 Option Award |
2025-02-24 4:30 pm |
N/A 2035-02-19 |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
402,000 | $0 | 1,551,290 (Direct) |
View |
2025-02-20 Option Award |
2025-02-24 4:30 pm |
N/A 2035-02-19 |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
108,000 | $0 | 159,653 (Direct) |
View |
2025-02-20 Option Award |
2025-02-24 4:30 pm |
N/A 2035-02-19 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
108,000 | $0 | 139,748 (Direct) |
View |
2025-02-20 Option Award |
2025-02-24 4:30 pm |
N/A 2035-02-19 |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
108,000 | $0 | 179,358 (Direct) |
View |
2025-02-03 Exercise |
2025-02-05 4:30 pm |
N/A 2032-10-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
5,000 | $0 | 150,790 (Direct) |
View |
2025-02-03 Exercise |
2025-02-05 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
5,000 | $16.89 | 150,790 (Direct) |
View |
2024-11-20 Ownership |
2025-01-29 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
451 | $14.98 | 71,809 (Direct) |
View |
2024-11-20 Ownership |
2025-01-29 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
473 | $14.98 | 112,038 (Direct) |
View |
2025-01-10 Option Award |
2025-01-13 4:30 pm |
N/A 2035-01-09 |
Crinetics Pharmaceuticals Inc. | CRNX | Kalofonos Isabel Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2025-01-07 Exercise |
2025-01-07 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
2,500 | $19.64 | 174,290 (Direct) |
View |
2025-01-03 Exercise |
2025-01-07 4:30 pm |
N/A 2032-10-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
17,500 | $0 | 174,290 (Direct) |
View |
2025-01-03 Exercise |
2025-01-07 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
15,000 | $16.89 | 174,290 (Direct) |
View |
2024-12-16 Exercise |
2024-12-18 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
2,331 | $1.91 | 251,397 (Direct) |
View |
2024-12-16 Exercise |
2024-12-18 4:30 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
2,331 | $0 | 251,397 (Direct) |
View |
2024-10-03 Exercise |
2024-10-07 07:55 am |
N/A 2032-10-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
14,375 | $0 | 167,549 (Direct) |
View |
2024-10-03 Exercise |
2024-10-07 07:55 am |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
14,375 | $16.89 | 167,549 (Direct) |
View |
2024-09-26 Exercise |
2024-09-30 5:01 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
25,000 | $15.29 | 200,092 (Direct) |
View |
2024-09-26 Exercise |
2024-09-30 5:01 pm |
N/A 2031-02-26 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
25,000 | $0 | 200,092 (Direct) |
View |
2024-07-25 Exercise |
2024-07-26 4:24 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
19,056 | $9.28 | 111,092 (Direct) |
View |
2024-07-25 Exercise |
2024-07-26 4:24 pm |
N/A 2028-05-24 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
19,056 | $0 | 111,092 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 5:35 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
5,687 | $19.64 | 269,680 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 5:35 pm |
N/A 2031-09-01 |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
26,073 | $0 | 269,680 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 5:35 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
17,499 | $23.98 | 269,680 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 5:35 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
2,887 | $20.02 | 269,680 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 5:14 pm |
N/A 2032-02-29 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
25,000 | $0 | 177,092 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 5:14 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
25,000 | $20.02 | 177,092 (Direct) |
View |
2024-07-05 Exercise |
2024-07-09 6:04 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
15,000 | $19.73 | 159,259 (Direct) |
View |
2024-07-05 Exercise |
2024-07-09 6:04 pm |
N/A 2032-03-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
15,000 | $0 | 159,259 (Direct) |
View |
2024-07-03 Exercise |
2024-07-05 4:30 pm |
N/A 2032-10-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
14,375 | $0 | 181,924 (Direct) |
View |
2024-07-03 Exercise |
2024-07-05 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
14,375 | $16.89 | 181,924 (Direct) |
View |
2024-06-28 Exercise |
2024-07-02 4:32 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
32,129 | $9.28 | 130,148 (Direct) |
View |
2024-06-28 Exercise |
2024-07-02 4:32 pm |
N/A 2028-05-24 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
32,129 | $0 | 130,148 (Direct) |
View |
2024-06-24 Exercise |
2024-06-25 5:03 pm |
N/A 2032-10-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
9,500 | $0 | 195,578 (Direct) |
View |
2024-06-24 Exercise |
2024-06-25 5:03 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer |
9,500 | $16.89 | 195,578 (Direct) |
View |
2024-06-21 Exercise |
2024-06-24 5:08 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
15,000 | $19.73 | 174,259 (Direct) |
View |
2024-06-21 Exercise |
2024-06-24 5:08 pm |
N/A 2032-03-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
15,000 | $0 | 174,259 (Direct) |
View |
2024-06-07 Option Award |
2024-06-11 4:21 pm |
N/A 2034-06-07 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
15,900 | $0 | 21,900 (Direct) |
View |
2024-06-07 Option Award |
2024-06-11 4:21 pm |
N/A 2034-06-07 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
15,900 | $0 | 26,900 (Direct) |
View |